RNY4 pseudogene 30 (RNY4P30)

RNY4 pseudogene 30 (RNY4P30) is a human pseudogene located on chromosome 13 (chr13:49889634-49889728, hg38)[3]. It is one of many non-coding RNA pseudogenes highly similar to the functional RNY4 gene, which belongs to the YRNA family. Pseudogenes like RNY4P30 typically do not produce functional products and their biological significance is often unclear. While parental YRNAs are implicated in processes such as DNA replication, RNA stability, alternative splicing, and have established roles as biomarkers in various cancers, RNY4 pseudogenes including RNY4P30 have not been demonstrated to be direct therapeutic targets or disease biomarkers. Some pseudogenes can regulate their parental genes by acting as competing endogenous RNAs or through interactions with RNA-binding proteins, but there are no specific published data describing such a role for RNY4 pseudogene 30[4]. Most published research and biomarker data relate to the functional RNY4 gene, not its pseudogenes[1][2][5]. Summary of assessment: RNY4P30 is not a validated therapeutic target, has no direct role in pathology or therapy, and all reported disease or biomarker research is linked to the parent gene RNY4, not to this pseudogene. There is inadequate evidence to assign biological functions, disease roles, or therapeutic relevance to this specific pseudogene.

Other names

RNY4P30RNA, Ro-associated Y4 pseudogene 30